Concerning glioblastoma (glioma grade IV, GBM), previous works reported the expansion of subsets of MDSCs (11–15) and an association of levels of CD11+/CD33+/HLA-DRlow/− MDSCs with survival (16). Here, CD33 is linked to glioblastoma.